MED19 Antikörper (Subunit 19)
-
- Target Alle MED19 Antikörper anzeigen
- MED19 (Mediator Complex Subunit 19 (MED19))
-
Bindungsspezifität
- Subunit 19
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MED19 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Human MED19
- Isotyp
- IgG
- Top Product
- Discover our top product MED19 Primärantikörper
-
anti-Mediator Complex Subunit 19 (MED19) (AA 68-117) antibody
MED19 Reaktivität: Human, Ratte, Maus, Rind (Kuh), Hund, Pferd, Kaninchen, Schwein, Fledermaus, Huhn, Hamster, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Mediator Complex Subunit 19 (MED19) (AA 161-188), (C-Term) antibodyMED19 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB37339 unconjugated
anti-Mediator Complex Subunit 19 (MED19) (AA 60-160) antibodyMED19 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Mediator Complex Subunit 19 (MED19) (N-Term) antibodyMED19 Reaktivität: Human, Ratte, Maus, Rind (Kuh), Hund, Pferd, Kaninchen, Meerschweinchen, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Other species are not tested. Please decide the specificity by homology
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % Sodium Azide, 50 % Glycerol, pH 7.3. -20 °C, Avoid freeze / thaw cycles.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid freeze and thaw cycles.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- MED19 (Mediator Complex Subunit 19 (MED19))
- Andere Bezeichnung
- MED19 (MED19 Produkte)
- Synonyme
- CG5546 antikoerper, Dmel\\CG5546 antikoerper, RGD1311926 antikoerper, 2410018M14Rik antikoerper, 3110040A13Rik antikoerper, LCMR1 antikoerper, lcmr1 antikoerper, DT2P1G7 antikoerper, lcmr1l antikoerper, med19 antikoerper, zgc:110121 antikoerper, zgc:153400 antikoerper, Mediator complex subunit 19 antikoerper, mediator complex subunit 19 antikoerper, mediator complex subunit 19 L homeolog antikoerper, mediator complex subunit 19b antikoerper, mediator complex subunit 19a antikoerper, MED19 antikoerper, Med19 antikoerper, med19 antikoerper, med19.L antikoerper, med19b antikoerper, med19a antikoerper
- Hintergrund
- LCMR1 antibody, Lung cancer metastasis related protein 1 antibody, Lung cancer metastasis-related protein 1 antibody, med19 antibody, MED19_HUMAN antibody, Mediator complex subunit 19 antibody, Mediator of RNA polymerase II transcription subunit 19 antibody
- UniProt
- Q8C1S0
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-
